- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01526044
Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients (RESCUEII)
Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients; a Randomized Controlled Trial (RESCUEII)
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Most patients admitted to the ICU are treated with intensive insulin therapy, according to a locally developed glucose treatment protocol. The use of a continuous glucose monitoring in critically ill patients could have the following advantages:
- Better insight in the alterations of the blood glucose levels
- Early detection of hypoglycemia's or hyperglycaemia's, and subsequently more stable glycemic levels.
- Fewer blood samples
- Decreased workload for the nursing staff
In this study, patients will be randomized in: 1. The Freestyle group or 2. The AccuChek Group.
Patients in both groups will receive a Freestyle Navigator device, which will stay on the patient up to 5 days, or until discharge from the ICU.
The medical treatment of both study groups will be equal, except for the frequency of the glucose level measurements and the resulting adjustments according to the treatment protocol. In the Freestyle group extra glucose level measurements will be made in response to alarms from the device.
In both groups, every 4 hours blood glucose values will be obtained using a blood gas analyzer (BGA). When a control measurement by BGA results in a glucose level of <2.2 or >25 mmol/l, the value will be transmitted to the Patient Data Management System (PDMS) and gives an alarm. Otherwise, the value will be blinded in the PDMS.
Freestyle Navigator data will be downloaded from the device. Blood glucose values obtained in the course of usual care will be compared with time-matched Freestyle Navigator values to assess device accuracy.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Amsterdam, Olanda
- Onze Lieve Vrouwe Gasthuis
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- ICU-patients > 18 years
- Expected length of stay on the ICU > 24 hours
- Indication for glucose regulation with insulin (according to the current glucose treatment protocol)
- Availability of the Freestyle Navigator
Exclusion Criteria:
- Participation in another trial subject to the WMO
- Lack of informed consent
- Contraindication for the use of the Accu Chek (for example peritoneal dialysis, Ht <0,20 of > 0,65; paracetamol intoxication)
- Contraindication for placement of the subcutaneous glucose sensor
- Participation in this trial during previous ICU admittance
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Diagnostico
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Freestyle group
Glucose levels are being monitored with the Freestyle Navigator up to 5 days, or until discharge from the ICU
|
Continuous glucose monitoring by subcutaneous measurement in the interstitial fluid
Altri nomi:
|
Comparatore attivo: AccuChek group
Glucose levels are being measured by the AccuChek.
Patients also get a Freestyle Navigator, which will be blinded.
The device will stay on the patient up to 5 days, or until discharge from the ICU.
|
Continuous glucose monitoring by subcutaneous measurement in the interstitial fluid
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
---|
Number of severe hyperglycaemias and hypoglycaemias with blood glucose levels >25 mmol/l and <2.2 mmol/l
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Mortalità
|
||
Length of stay in the ICU
|
||
Time duration that the blood glucose levels of a patient are within the 'target range' (measured with the freestyle Navigator®)
|
The target range in the ICU of the OLVG is set between 5 and 9 mmol/l according to the local treatment protocol
|
|
Time duration that the blood glucose levels of a patient are under and above the 'target range' (measured with the freestyle Navigator®)
|
The target range in the ICU of the OLVG is set between 5 and 9 mmol/l according to the local treatment protocol
|
|
- Variability of the glycemic levels by arterial measuring with the blood gas analyzer (BGA), determined by the Mean Absolute Glucose change per hour (MAG)
|
Mean Absolute Glucose change per hour: ΔBGA / Δtime The MAG is calculated by taking the sum of all absolute glucose changes during admission (measured by BGA) and dividing this by the total time spent in the ICU in hours. |
|
False positive frequency of alarms of the Freestyle Navigator®
|
Verified by the glucose level measurements by blood gas analyzer
|
|
Number of undesirable low glucose levels per 24 hours
Lasso di tempo: 24 hours
|
blood glucose levels between 2,5 and 5 mmol/l
|
24 hours
|
Number of missed hypoglycemia's with the AccuChek (measured with the Freestyle Navigator®)
|
||
Number of blood samples per day
Lasso di tempo: 24 hours
|
24 hours
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: P HJ van der Voort, MD, PhD, Onze Lieve Vrouwe Gasthuis
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- NL33495.100.10
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Freestyle Navigator
-
University Medical Centre LjubljanaKarolinska Institutet; Schneider Children's Medical Center, IsraelCompletatoIpoglicemia | Diabete mellito, tipo 1Svezia, Israele, Slovenia
-
Lawson Health Research InstituteBoston Scientific CorporationTerminato
-
Florida State UniversityNational Institute of Mental Health (NIMH); Emory University; Weill Medical College... e altri collaboratoriCompletatoDisturbo dello spettro autisticoStati Uniti
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Reclutamento
-
University of CalgaryAttivo, non reclutanteIpertensione | Diabete mellito, tipo 2 | Malattie renali croniche | Broncopneumopatia cronica ostruttiva | Asma | Cardiopatia ischemica | Insufficienza cardiaca congestiziaCanada
-
University of Wisconsin, MadisonAurora Health CareTerminatoCancro al seno | Cancro colorettale | Cancro ai polmoni | Cancro alla prostataStati Uniti
-
University of California, RiversideNational Institute of Mental Health (NIMH); University of California, Los Angeles e altri collaboratoriNon ancora reclutamentoDepressione | Ansia | Problema di salute mentale
-
University of CalgaryUniversity of AlbertaAttivo, non reclutanteIpertensione | Diabete mellito, tipo 2 | Malattie renali croniche | Broncopneumopatia cronica ostruttiva | Asma | Cardiopatia ischemica | Insufficienza cardiaca congestiziaCanada
-
Abbott Diabetes CareLiverpool University Hospitals NHS Foundation Trust; NHS Lothian; Cardiff and Vale... e altri collaboratoriCompletato
-
Assistance Publique - Hôpitaux de ParisSconosciutoCancro al seno | Chirurgia | Cancro della pelle | AmbulatorioFrancia